Drug Database
Back to search

Netherlands· NL-a775b175397b

mNEXSPIKE dispersie voor injectie in een voorgevulde spuit COVID-19-mRNA-vaccin

A covid-19, rna-based vaccine product containing recombinant sars-cov-2 spike-eiwit xbb.1.5 variant, registered in Netherlands by Moderna Biotech Spain S.L.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedmNEXSPIKE dispersie voor injectie in …ATCJ07BN01REGISTER NO.NL-a775b175397bPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about recombinant sars-cov-2 spike-eiwit xbb.1.5 variantAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RECOMBINANT SARS-CoV-2 SPIKE-EIWIT XBB.1.5 VARIANT
Manufacturer
Moderna Biotech Spain S.L.
Country
Netherlands (NL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/2010

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc3193ff-9db6-4775-a8d9-5c03a789d06d
GET /v1/drugs/fc3193ff-9db6-4775-a8d9-5c03a789d06d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mnexspike-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134387",
  "excipients": [
    "1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLEENGLYCOL-2000",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "CHOLESTEROL",
    "HEPTADECAAN-9-YL 8-((2-HYDROXYETHYL)(6-OXO-6-(UNDECYLOXY) HEXYL) AMINO) OCTANOAAT",
    "SACCHAROSE",
    "TROMETAMOL",
    "TROMETAMOLHYDROCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "RECOMBINANT SARS-CoV-2 SPIKE-EIWIT XBB.1.5 VARIANT"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/02/12",
  "procedure_number": "EMEA/H/C/006428",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/2010",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console